The contract development and manufacturing organization (CDMO), Particle Sciences, a Lubrizol LifeSciences company, has strengthened its nanomilling offering with the launch of a new Nanomilling Feasibility Program.   The program is designed to assess nanomilling as a dissolution/solubility enhancement option for a client’s active pharmaceutical ingredient (API). In as little as eight weeks, Particle Sciences will nanomill an API with GRAS-approved excipients, measure particle size distr...